Results 81 to 90 of about 186,092 (190)

Syncope in Elderly People: A Threatening Presentation of Pulmonary Embolism: A Case Report [PDF]

open access: yes, 2015
age. Its prognosis is largely unpredictable, pending the origin of the sudden loss of consciousness. We report a case of an old woman affected by severe chronic heart failure, who died soon after the development of an episode of syncope, which was ...
Bilora, Franca   +3 more
core  

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

open access: yesKidney & Blood Pressure Research, 2020
Alessandra F. Perna   +5 more
doaj   +1 more source

Update on the clinical use of the low-molecular-weight heparin, parnaparin

open access: yesVascular Health and Risk Management, 2009
Giuseppe Camporese1, Enrico Bernardi2, Franco Noventa31Unit of Angiology and 3Department of Clinical and Experimental Medicine, Clinical Epidemiology Group, University Hospital of Padua, Italy; 2Department of Emergency and Accident Medicine, Hospital of ...
Giuseppe Camporese   +2 more
doaj  

What's the best way to manage upper extremity venous thrombosis? [PDF]

open access: yes, 2010
Standard management is best: Start with unfractionated heparin or low-molecular-weight heparin and follow with long-term therapy with a vitamin K antagonist (strength of recommendation [SOR]: C, expert consensus and case reports).
Goodemote, Patricia   +2 more
core  

Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis

open access: yesThrombosis Journal
Background Sepsis is a life-threatening condition that affects 49 million people annually. Managing sepsis-associated coagulopathy poses a significant challenge due to its high mortality rates in intensive care.
Takaaki Totoki   +6 more
doaj   +1 more source

The methods of assessment of quality and safety of medicaments on the basis of low molecular weight heparins

open access: yesСеченовский вестник, 2011
To consider the methods for assessing quality and safety of drugs on the basis of low molecular weight heparin.
E. A. Arianova   +2 more
doaj  

Low-Molecular-Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis: Protocol for the INCEPT-Thromboprophylaxis Platform Trial Domain. [PDF]

open access: yesActa Anaesthesiol Scand
Eck R   +10 more
europepmc   +1 more source

Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparin. [PDF]

open access: yesRes Pract Thromb Haemost
van Haaps TF   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy